JAMIE DAMICO: Open Payments
NPI 1982062170 · OCEAN SPRINGS, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,508 in 195 payments from 26 companies in 2025. Trend: 2023 $3,281 · 2024 $3,488 · 2025 $3,508
Food & beverage: $3,476Education: $33
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 48 | $721 |
| UCB, Inc. | 20 | $380 |
| Alexion Pharmaceuticals, Inc. | 11 | $244 |
| ACADIA Pharmaceuticals Inc | 16 | $228 |
| Neurocrine BioSciences, Inc. | 9 | $223 |
| PFIZER INC. | 14 | $200 |
| Biogen, Inc. | 9 | $185 |
| Genentech USA, Inc. | 7 | $160 |
| Lundbeck LLC | 10 | $137 |
| SK Life Science, Inc. | 5 | $124 |
Products named: BOTOX, ULTOMIRIS, QULIPTA, NUPLAZID, INGREZZA, NURTEC ODT, Zilbrysq, Ocrevus Zunovo.
Industry payments across MS — which companies pay providers there.
